Welcome to our dedicated page for Cutera news (Ticker: CUTR), a resource for investors and traders seeking the latest updates and insights on Cutera stock.
Cutera, Inc. (symbol: CUTR) is a leading innovator in the field of medical aesthetics, specializing in the design, development, manufacturing, marketing, and servicing of energy-based aesthetic systems. Established in 1998 by experienced laser and optical engineers in Brisbane, California, Cutera has grown to become a trusted authority in face and body energy-based medical aesthetic technologies.
Cutera pioneered Nd:YAG technology and has continued to innovate, offering a premium portfolio of products that include Xeo®, truSculpt®, and excel V™. In 2014, the company expanded its product line with two significant additions: excel HR™, which provides high-speed, comfortable hair removal, and enlighten™, the industry's first system combining picosecond and nanosecond wavelengths.
With a presence in over 40 countries and direct operations in North America, France, Australia, Japan, and Hong Kong, Cutera is committed to meeting the evolving needs of the medical aesthetic community. Their solutions are designed to deliver better results, faster and safer than ever before.
The company markets its products under various trademarks, including Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis Plus, Pico-genesis, Titan, truSculpt, and Xeo. Cutera derives the majority of its revenue from the United States but maintains a strong international presence.
Recent achievements include the introduction of innovative products that have set new industry standards. Cutera's focus on research and development ensures that they remain at the forefront of the medical aesthetic technology market, continuously providing advanced solutions to practitioners worldwide.
For the latest updates and relevant information about Cutera's performance, events, and developments, stay tuned to Cutera's news section on StockTitan.
Cutera, Inc. (Nasdaq: CUTR) reported Q1 2024 financial results with revenue of $38.8 million, a 29% decrease from the previous year. The company highlighted a strong sequential increase in AviClear revenue and the successful launch of xeo+. Gross profit was $12.4 million, operating expenses were $31.9 million, and cash equivalents were $105.4 million. Cutera reiterated its 2024 revenue guidance of $160-170 million.
FAQ
What is the current stock price of Cutera (CUTR)?
What is the market cap of Cutera (CUTR)?
What does Cutera, Inc. specialize in?
When was Cutera, Inc. established?
What are some of Cutera’s key products?
Where is Cutera, Inc. headquartered?
In how many countries does Cutera have a presence?
What technology did Cutera pioneer?
Where does Cutera derive the majority of its revenue?
What is the significance of the product excel HR™?
What is unique about the enlighten™ system?
How does Cutera stay at the forefront of the industry?
